Drugs / Iron protein succinylate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03344523 | Jan 2018 → Dec 2019 | disorder of iron metabolism and transport, heart failure | Lee's Pharmaceutical Limited | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Iron protein succinylate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03344523 ↗ |
| Route | Oral | “1 bottle orally, twice daily, take orally before meals” NCT03344523 ↗ |